It is a pharma public limited company based in Gurgaon, Haryana, India, established in 2013.
2013 | Gurgaon, Haryana, India | Struck OffSereno Pharma Limited, a struck off public limited company, was established on 10 June 2013 in Gurgaon, Haryana, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24232HR2013PLC049495. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹6.95 M.
It upholds a active non-compliant status. Its leadership includes Vutla Nagabhushanam (Director), Kakani Srinivasa Rao (Director), Pratibha Vijayan Nair (Director). Past directors included Pratibha Vijayan Nair, Niraj Varma. Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at Unit No. 0707,Block-A, Seventh Floor, Unitech Arcadia, South City-Ii, Sohna Ro, Ad, Gurgaon, Haryana, 122018.
U24232HR2013PLC049495
049495
10 June 2013
₹1.00 Cr
₹6.95 M
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Sereno Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vutla Nagabhushanam | Director | 10 Jun 2013 | Current |
| Kakani Srinivasa Rao | Director | 10 Jun 2013 | Current |
| Pratibha Vijayan Nair | Director | 13 Aug 2014 | Current |
| Katipalli Ram Prasad Reddy | Director | 10 Jun 2013 | Current |
| Niraj Varma | Director | 13 Aug 2014 | Current |
| Sanjay Chowdary Mannepalli | Director | 10 Jun 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Sep 2017 | Past |
| Pramod Abcsdd | Director | 10 Aug 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Sereno Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2016, Sereno Pharma had a promoter holding of 21.53% and a public holding of 78.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sereno Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sereno Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sereno Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sereno Pharma Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was documented.
The activity Sereno Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Delhi. was completed.
Progress on Madhavi Vutla was appointed as a Director was appointed as a Director on 25 Jul 2015 & has been associated with this company since 10 years 4 months . was documented.
Pratibha Vijayan Nair was appointed as a Director was appointed as a Director on 13 Aug 2014 & has been associated with this company since 11 years 3 months . was recorded as a recent event.
Niraj Varma was appointed as a Director was appointed as a Director on 13 Aug 2014 & has been associated with this company since 11 years 3 months . was recorded as a recent event.
Progress on Rajesh Kumar was appointed as a Director was appointed as a Director on 13 Aug 2014 & has been associated with this company since 11 years 3 months . was documented.
The CIN of Sereno Pharma Limited is U24232HR2013PLC049495.
Sereno Pharma Limited is headquartered at Unit No. 0707,Block-A, Seventh Floor, Unitech Arcadia, South City-Ii, Sohna Ro, Ad, Gurgaon, Haryana, 122018.
Sereno Pharma Limited was incorporated on 10 June 2013.
The current directors of Sereno Pharma Limited are
The primary industry of Sereno Pharma Limited is Pharma.
Sereno Pharma Limited is unlisted.
The authorized capital of Sereno Pharma Limited is ₹1.00 Cr, and the paid-up capital is ₹6.95 M.
The compliance status of Sereno Pharma Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX